Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,495.49
1,387.17
1,413.51
1,281.18
1,137.40
942.46
817.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,495.49
1,387.17
1,413.51
1,281.18
1,137.40
942.46
817.55
Raw Material Cost
627.78
567.21
532.23
437.36
326.26
265.00
254.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
185.43
125.17
121.36
99.18
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.87
0.29
0.12
0.16
0.17
0.05
0.04
Selling and Distribution Expenses
595.56
532.51
577.52
585.68
580.40
458.75
392.65
Other Expenses
-6.38
2.39
-2.66
-1.92
6.75
6.19
4.36
Total Expenditure (Excl Depreciation)
1,345.88
1,249.03
1,204.66
1,103.16
974.30
785.69
690.53
Operating Profit (PBDIT) excl Other Income
149.60000000000002
138.1
208.9
178
163.1
156.8
127
Other Income
53.47
48.30
37.55
32.91
29.15
15.00
7.97
Operating Profit (PBDIT)
269.09
252.83
302.64
248.90
219.19
194.11
153.87
Interest
0.87
0.29
0.12
0.16
0.17
0.05
0.04
Exceptional Items
72.69
0.00
-5.27
0.00
-2.15
0.09
0.01
Gross Profit (PBDT)
867.71
819.96
881.28
843.82
811.14
677.45
563.29
Depreciation
76.65
72.12
62.32
49.02
34.28
29.67
26.19
Profit Before Tax
264.26
180.42
234.92
199.72
182.59
164.48
127.65
Tax
12.80
22.92
36.84
21.57
19.27
19.45
11.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
238.28
164.32
211.32
182.80
160.76
145.03
116.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
238.28
164.32
211.32
182.80
160.76
145.03
116.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.18
-25.56
-18.28
-9.42
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
228.10
138.76
193.04
173.39
160.76
145.03
116.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
2,042.68
1,803.41
1,723.51
1,596.61
1,479.47
663.05
553.17
Earnings per share (EPS)
1.77
1.25
1.61
1.39
1.22
1.1
0.88
Diluted Earnings per share
1.77
1.25
1.61
1.39
1.22
1.1
0.88
Operating Profit Margin (Excl OI)
9.29%
9.55%
14.34%
13.03%
13.69%
15.86%
14.64%
Gross Profit Margin
22.8%
18.21%
21.03%
19.42%
19.07%
20.6%
18.82%
PAT Margin
15.93%
11.85%
14.95%
14.27%
14.13%
15.39%
14.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 7.81% vs -1.86% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 64.34% vs -28.08% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 5.43% vs -22.86% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 200.00% vs 200.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Hunan Warrant Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,495.49
0
1,495.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,495.49
0
1,495.49
Raw Material Cost
627.78
0
627.78
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
185.43
0
185.43
Power Cost
0
0
0.00
Manufacturing Expenses
0.87
0
0.87
Selling and Distribution Expenses
595.56
0
595.56
Other Expenses
-6.38
0.00
-6.38
Total Expenditure (Excl Depreciation)
1,345.88
0
1,345.88
Operating Profit (PBDIT) excl Other Income
149.61
0.00
149.61
Other Income
53.47
0
53.47
Operating Profit (PBDIT)
269.09
0
269.09
Interest
0.87
0
0.87
Exceptional Items
72.69
0
72.69
Gross Profit (PBDT)
867.71
0
867.71
Depreciation
76.65
0
76.65
Profit Before Tax
264.26
0
264.26
Tax
12.80
0
12.80
Provisions and contingencies
0
0
0.00
Profit After Tax
238.28
0
238.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
238.28
0
238.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.18
0
-10.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
228.10
0
228.10
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,042.68
0
2,042.68
Earnings per share (EPS)
1.77
0
1.77
Diluted Earnings per share
1.77
0
1.77
Operating Profit Margin (Excl OI)
9.29%
0%
0.00
9.29%
Gross Profit Margin
22.80%
0%
0.00
22.80%
PAT Margin
15.93%
0%
0.00
15.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 149.55 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 7.81% vs -1.86% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 22.81 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 64.34% vs -28.08% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.43% vs -22.86% in Dec 2024
Annual - Interest
Interest 0.09 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 200.00% vs 200.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.29%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






